English

TREGA BIOSCIENCES INC

EDGAR

Quarterly report (10-Q) · filed 2000-11-14

21 filing records in this dataset, filed from 1996-05-15 to 2000-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.41 million USD

2000-09-30 · USD

Exact inputs and evidence

Revenue: 3410000 USD Source

Operating margin

-118.39%

2000-09-30 · %

Exact inputs and evidence

Operating Income: -4037000 USD Source
Revenue: 3410000 USD Source

Operating cash flow

-3.89 million USD

2000-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -11460000 USD Source
Operating Cash Flow: -7569000 USD Source

Free cash flow

-4.63 million USD

2000-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -11460000 USD Source
Operating Cash Flow: -7569000 USD Source
Capital Expenditure: 1498000 USD Source
Capital Expenditure: 755000 USD Source

Cash and cash equivalents: 2.24 million USD 2000-09-30 Source
Exact value

2238000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-11.7 million USD

1999-10-01 – 2000-09-30

Exact inputs and evidence

Net income: -8673000 USD · 1999-01-01 – 1999-12-31 Source
Net income: -8511000 USD · 1999-01-01 – 1999-09-30 Source
Net income: -4300000 USD · 2000-01-01 – 2000-03-31 Source
Net income: -3148000 USD · 2000-04-01 – 2000-06-30 Source
Net income: -4115000 USD · 2000-07-01 – 2000-09-30 Source

Operating cash flow

-12.7 million USD

1999-10-01 – 2000-09-30

Exact inputs and evidence

Operating cash flow: -12567000 USD · 1999-01-01 – 1999-12-31 Source
Operating cash flow: -11291000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -3665000 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: -7569000 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -3665000 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: -11460000 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -7569000 USD · 2000-01-01 – 2000-06-30 Source

Capital expenditure

2.04 million USD

1999-10-01 – 2000-09-30

Exact inputs and evidence

Capital expenditure: 1656000 USD · 1999-01-01 – 1999-12-31 Source
Capital expenditure: 1117000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 543000 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 755000 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 543000 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 1498000 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 755000 USD · 2000-01-01 – 2000-06-30 Source

Free cash flow

-14.8 million USD

1999-10-01 – 2000-09-30

Exact inputs and evidence

Operating cash flow: -12567000 USD · 1999-01-01 – 1999-12-31 Source
Operating cash flow: -11291000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -3665000 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: -7569000 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -3665000 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: -11460000 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -7569000 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 1656000 USD · 1999-01-01 – 1999-12-31 Source
Capital expenditure: 1117000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 543000 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 755000 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 543000 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 1498000 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 755000 USD · 2000-01-01 – 2000-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-11-14.

Financial data available through: 1999-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 1999-12-31
Operating income: 6 of 11 periods available· newest 1999-12-31
Net income: 6 of 11 periods available· newest 1999-12-31
Operating cash flow: 6 of 11 periods available· newest 1999-12-31
Capital expenditure: 6 of 11 periods available· newest 1999-12-31
Total assets: 5 of 11 periods available· newest 1999-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 1999-12-31
Current liabilities: 5 of 11 periods available· newest 1999-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 1999-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+24%

Prior period

USD 10.79 million

1998-01-01 – 1998-12-31
Current period

USD 13.38 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

13377000 − 10790000 = 2587000 USD

10790000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
13377000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · TREGA BIOSCIENCES INC · 1999-12-31 TREGA BIOSCIENCES INC (edgar:887920) Year-over-year change in Revenue: 2587000 USD Concept: fundies:Revenue Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 13377000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3644 Input fundies:Revenue: 10790000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3644
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 4.13 million

Prior period

−USD 12.8 million

1998-01-01 – 1998-12-31
Current period

−USD 8.67 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-8673000 − -12801000 = 4128000 USD

-12801000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-8673000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · TREGA BIOSCIENCES INC · 1999-12-31 TREGA BIOSCIENCES INC (edgar:887920) Year-over-year change in Net income: 4128000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -8673000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3761 Input fundies:NetIncome: -12801000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3761
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.23 million

Prior period

−USD 7.34 million

1998-01-01 – 1998-12-31
Current period

−USD 12.57 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-12567000 − -7342000 = -5225000 USD

-7342000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-12567000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · TREGA BIOSCIENCES INC · 1999-12-31 TREGA BIOSCIENCES INC (edgar:887920) Year-over-year change in Operating cash flow: -5225000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -12567000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3785 Input fundies:OperatingCashFlow: -7342000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3785
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-40.6%

Prior period

USD 2.79 million

1998-01-01 – 1998-12-31
Current period

USD 1.66 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

1656000 − 2788000 = -1132000 USD

2788000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
1656000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · TREGA BIOSCIENCES INC · 1999-12-31 TREGA BIOSCIENCES INC (edgar:887920) Year-over-year change in Capital expenditure: -1132000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1656000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3790 Input fundies:CapitalExpenditure: 2788000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3790
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1999 1999-01-01 – 1999-12-31

Revenue USD 13.38 million 100% of revenue
Cost of revenue USD 332,000 2.5% of revenue
Operating expenses USD 7.34 million 55% of revenue
Other operating costs Derived USD 17.97 million 134% of revenue
Operating income −USD 12.27 million −92% of revenue
Tax, interest and other Derived −USD 3.6 million −27% of revenue
Net income −USD 8.67 million −65% of revenue

Cash

Operating cash flow −USD 12.57 million −94% of revenue
Capital expenditure USD 1.66 million 12% of revenue
Free cash flow Derived −USD 14.22 million −106% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Operating loss: operating costs were 1,443% of revenue.
1995 Operating loss: operating costs were 827% of revenue.
1996 Operating loss: operating costs were 249% of revenue.
1997 Operating loss: operating costs were 251% of revenue.
1998 Operating loss: operating costs were 224% of revenue.
1999 Operating loss: operating costs were 192% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	630000	9092000 Derived	-8462000	590000 Derived	-9052000	-8073000 Derived	Source 1994-01-01 – 1994-12-31: 630000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -8462000 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -9052000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -7941000 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 132000 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	1370000	11324000 Derived	-9954000	-464000 Derived	-9490000	-7065000 Derived	Source 1995-01-01 – 1995-12-31: 1370000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -9954000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -9490000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -6931000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 134000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	8257000	20582000 Derived	-12325000	-637000 Derived	-11688000	-10405000 Derived	Source 1996-01-01 – 1996-12-31: 8257000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -12325000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -11688000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -9607000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 798000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	7764000	19506000 Derived	-11742000	-2370000 Derived	-9372000	-11117000 Derived	Source 1997-01-01 – 1997-12-31: 7764000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -11742000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -9372000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -9072000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 2045000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	10790000	24122000 Derived	-13332000	-531000 Derived	-12801000	-10130000 Derived	Source 1998-01-01 – 1998-12-31: 10790000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -13332000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -12801000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -7342000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 2788000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	13377000	25645000 Derived	-12268000	-3595000 Derived	-8673000	-14223000 Derived	Source 1999-01-01 – 1999-12-31: 13377000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -12268000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -8673000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -12567000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 1656000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 13.4M 1999

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	630000	Revenue: 630000 Open source
19951995-12-31	Revenue	1370000	Revenue: 1370000 Open source
19961996-12-31	Revenue	8257000	Revenue: 8257000 Open source
19971997-12-31	Revenue	7764000	Revenue: 7764000 Open source
19981998-12-31	Revenue	10790000	Revenue: 10790000 Open source
19991999-12-31	Revenue	13377000	Revenue: 13377000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

24% 1999

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 630000 Open source
19951995-12-31	Year over year	117.5%	Revenue: 1370000 Open source Revenue: 630000 Open source
19961996-12-31	Year over year	502.7%	Revenue: 8257000 Open source Revenue: 1370000 Open source
19971997-12-31	Year over year	-6%	Revenue: 7764000 Open source Revenue: 8257000 Open source
19981998-12-31	Year over year	39%	Revenue: 10790000 Open source Revenue: 7764000 Open source
19991999-12-31	Year over year	24%	Revenue: 13377000 Open source Revenue: 10790000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -91.7% 1999

Net margin -64.8% 1999

Free cash flow margin -106.3% 1999

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	-1,343.2%	Operating Income: -8462000 Open source Revenue: 630000 Open source
19951995-12-31	Operating margin	-726.6%	Operating Income: -9954000 Open source Revenue: 1370000 Open source
19961996-12-31	Operating margin	-149.3%	Operating Income: -12325000 Open source Revenue: 8257000 Open source
19971997-12-31	Operating margin	-151.2%	Operating Income: -11742000 Open source Revenue: 7764000 Open source
19981998-12-31	Operating margin	-123.6%	Operating Income: -13332000 Open source Revenue: 10790000 Open source
19991999-12-31	Operating margin	-91.7%	Operating Income: -12268000 Open source Revenue: 13377000 Open source
19941994-12-31	Net margin	-1,436.8%	Net Income: -9052000 Open source Revenue: 630000 Open source
19951995-12-31	Net margin	-692.7%	Net Income: -9490000 Open source Revenue: 1370000 Open source
19961996-12-31	Net margin	-141.6%	Net Income: -11688000 Open source Revenue: 8257000 Open source
19971997-12-31	Net margin	-120.7%	Net Income: -9372000 Open source Revenue: 7764000 Open source
19981998-12-31	Net margin	-118.6%	Net Income: -12801000 Open source Revenue: 10790000 Open source
19991999-12-31	Net margin	-64.8%	Net Income: -8673000 Open source Revenue: 13377000 Open source
19941994-12-31	Free cash flow margin	-1,281.4%	Revenue: 630000 Open source Operating Cash Flow: -7941000 Open source Capital Expenditure: 132000 Open source
19951995-12-31	Free cash flow margin	-515.7%	Revenue: 1370000 Open source Operating Cash Flow: -6931000 Open source Capital Expenditure: 134000 Open source
19961996-12-31	Free cash flow margin	-126%	Revenue: 8257000 Open source Operating Cash Flow: -9607000 Open source Capital Expenditure: 798000 Open source
19971997-12-31	Free cash flow margin	-143.2%	Revenue: 7764000 Open source Operating Cash Flow: -9072000 Open source Capital Expenditure: 2045000 Open source
19981998-12-31	Free cash flow margin	-93.9%	Revenue: 10790000 Open source Operating Cash Flow: -7342000 Open source Capital Expenditure: 2788000 Open source
19991999-12-31	Free cash flow margin	-106.3%	Revenue: 13377000 Open source Operating Cash Flow: -12567000 Open source Capital Expenditure: 1656000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -12.6M 1999

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-7941000	Operating Cash Flow: -7941000 Open source
19951995-12-31	Operating cash flow	-6931000	Operating Cash Flow: -6931000 Open source
19961996-12-31	Operating cash flow	-9607000	Operating Cash Flow: -9607000 Open source
19971997-12-31	Operating cash flow	-9072000	Operating Cash Flow: -9072000 Open source
19981998-12-31	Operating cash flow	-7342000	Operating Cash Flow: -7342000 Open source
19991999-12-31	Operating cash flow	-12567000	Operating Cash Flow: -12567000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.2M 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-8073000	Operating Cash Flow: -7941000 Open source Capital Expenditure: 132000 Open source
19951995-12-31	Free cash flow	-7065000	Operating Cash Flow: -6931000 Open source Capital Expenditure: 134000 Open source
19961996-12-31	Free cash flow	-10405000	Operating Cash Flow: -9607000 Open source Capital Expenditure: 798000 Open source
19971997-12-31	Free cash flow	-11117000	Operating Cash Flow: -9072000 Open source Capital Expenditure: 2045000 Open source
19981998-12-31	Free cash flow	-10130000	Operating Cash Flow: -7342000 Open source Capital Expenditure: 2788000 Open source
19991999-12-31	Free cash flow	-14223000	Operating Cash Flow: -12567000 Open source Capital Expenditure: 1656000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
1995-12-31	Liabilities / assets	Not reported	Total Assets: 2746000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 30513000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 25119000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 29535000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 22661000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.1× 1999

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	0.4×	Current Assets: 1534000 Open source Current Liabilities: 3879000 Open source
19961996-12-31	Current assets / current liabilities	4.93×	Current Assets: 28206000 Open source Current Liabilities: 5724000 Open source
19971997-12-31	Current assets / current liabilities	2.75×	Current Assets: 20103000 Open source Current Liabilities: 7312000 Open source
19981998-12-31	Current assets / current liabilities	1.9×	Current Assets: 17040000 Open source Current Liabilities: 8983000 Open source
19991999-12-31	Current assets / current liabilities	1.1×	Current Assets: 8975000 Open source Current Liabilities: 8155000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 9.05 million Exact value Exact value: -9052000 USD 1994-01-01 – 1994-12-31: -9052000 USD Inspect Net Income Open source Share or cite Citation for Net Income · TREGA BIOSCIENCES INC · 1994-12-31 TREGA BIOSCIENCES INC (edgar:887920) Net Income: -9052000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9052000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-97-000429.txt#3021 The citation records this snapshot. The page link may show a newer release later.	−USD 7.94 million Exact value Exact value: -7941000 USD 1994-01-01 – 1994-12-31: -7941000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TREGA BIOSCIENCES INC · 1994-12-31 TREGA BIOSCIENCES INC (edgar:887920) Operating Cash Flow: -7941000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7941000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-97-000429.txt#3039 The citation records this snapshot. The page link may show a newer release later.	USD 132,000 Exact value Exact value: 132000 USD 1994-01-01 – 1994-12-31: 132000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TREGA BIOSCIENCES INC · 1994-12-31 TREGA BIOSCIENCES INC (edgar:887920) Capital Expenditure: 132000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 132000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-97-000429.txt#3042 The citation records this snapshot. The page link may show a newer release later.	−USD 8.07 million Calculation and evidence -7941000 − 132000 USD Exact free cash flow: -8073000 USD 1994-01-01 – 1994-12-31: -7941000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 132000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TREGA BIOSCIENCES INC · 1994-12-31 TREGA BIOSCIENCES INC (edgar:887920) Free cash flow: -8073000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7941000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-97-000429.txt#3039 Input fundies:CapitalExpenditure: 132000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-97-000429.txt#3042 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 9.49 million Exact value Exact value: -9490000 USD 1995-01-01 – 1995-12-31: -9490000 USD Inspect Net Income Open source Share or cite Citation for Net Income · TREGA BIOSCIENCES INC · 1995-12-31 TREGA BIOSCIENCES INC (edgar:887920) Net Income: -9490000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9490000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-98-000532.txt#3140 The citation records this snapshot. The page link may show a newer release later.	−USD 6.93 million Exact value Exact value: -6931000 USD 1995-01-01 – 1995-12-31: -6931000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TREGA BIOSCIENCES INC · 1995-12-31 TREGA BIOSCIENCES INC (edgar:887920) Operating Cash Flow: -6931000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6931000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-98-000532.txt#3162 The citation records this snapshot. The page link may show a newer release later.	USD 134,000 Exact value Exact value: 134000 USD 1995-01-01 – 1995-12-31: 134000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TREGA BIOSCIENCES INC · 1995-12-31 TREGA BIOSCIENCES INC (edgar:887920) Capital Expenditure: 134000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 134000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-98-000532.txt#3167 The citation records this snapshot. The page link may show a newer release later.	−USD 7.07 million Calculation and evidence -6931000 − 134000 USD Exact free cash flow: -7065000 USD 1995-01-01 – 1995-12-31: -6931000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 134000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TREGA BIOSCIENCES INC · 1995-12-31 TREGA BIOSCIENCES INC (edgar:887920) Free cash flow: -7065000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6931000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-98-000532.txt#3162 Input fundies:CapitalExpenditure: 134000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000936392-98-000532.txt#3167 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 11.69 million Exact value Exact value: -11688000 USD 1996-01-01 – 1996-12-31: -11688000 USD Inspect Net Income Open source Share or cite Citation for Net Income · TREGA BIOSCIENCES INC · 1996-12-31 TREGA BIOSCIENCES INC (edgar:887920) Net Income: -11688000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11688000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0001047469-99-012761.txt#2767 The citation records this snapshot. The page link may show a newer release later.	−USD 9.61 million Exact value Exact value: -9607000 USD 1996-01-01 – 1996-12-31: -9607000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TREGA BIOSCIENCES INC · 1996-12-31 TREGA BIOSCIENCES INC (edgar:887920) Operating Cash Flow: -9607000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9607000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0001047469-99-012761.txt#2790 The citation records this snapshot. The page link may show a newer release later.	USD 798,000 Exact value Exact value: 798000 USD 1996-01-01 – 1996-12-31: 798000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TREGA BIOSCIENCES INC · 1996-12-31 TREGA BIOSCIENCES INC (edgar:887920) Capital Expenditure: 798000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 798000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0001047469-99-012761.txt#2795 The citation records this snapshot. The page link may show a newer release later.	−USD 10.41 million Calculation and evidence -9607000 − 798000 USD Exact free cash flow: -10405000 USD 1996-01-01 – 1996-12-31: -9607000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 798000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TREGA BIOSCIENCES INC · 1996-12-31 TREGA BIOSCIENCES INC (edgar:887920) Free cash flow: -10405000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9607000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0001047469-99-012761.txt#2790 Input fundies:CapitalExpenditure: 798000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0001047469-99-012761.txt#2795 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 9.37 million Exact value Exact value: -9372000 USD 1997-01-01 – 1997-12-31: -9372000 USD Inspect Net Income Open source Share or cite Citation for Net Income · TREGA BIOSCIENCES INC · 1997-12-31 TREGA BIOSCIENCES INC (edgar:887920) Net Income: -9372000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9372000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3761 The citation records this snapshot. The page link may show a newer release later.	−USD 9.07 million Exact value Exact value: -9072000 USD 1997-01-01 – 1997-12-31: -9072000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TREGA BIOSCIENCES INC · 1997-12-31 TREGA BIOSCIENCES INC (edgar:887920) Operating Cash Flow: -9072000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9072000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3785 The citation records this snapshot. The page link may show a newer release later.	USD 2.05 million Exact value Exact value: 2045000 USD 1997-01-01 – 1997-12-31: 2045000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TREGA BIOSCIENCES INC · 1997-12-31 TREGA BIOSCIENCES INC (edgar:887920) Capital Expenditure: 2045000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2045000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3790 The citation records this snapshot. The page link may show a newer release later.	−USD 11.12 million Calculation and evidence -9072000 − 2045000 USD Exact free cash flow: -11117000 USD 1997-01-01 – 1997-12-31: -9072000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 2045000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TREGA BIOSCIENCES INC · 1997-12-31 TREGA BIOSCIENCES INC (edgar:887920) Free cash flow: -11117000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9072000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3785 Input fundies:CapitalExpenditure: 2045000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3790 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 12.8 million Exact value Exact value: -12801000 USD 1998-01-01 – 1998-12-31: -12801000 USD Inspect Net Income Open source Share or cite Citation for Net Income · TREGA BIOSCIENCES INC · 1998-12-31 TREGA BIOSCIENCES INC (edgar:887920) Net Income: -12801000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12801000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3761 The citation records this snapshot. The page link may show a newer release later.	−USD 7.34 million Exact value Exact value: -7342000 USD 1998-01-01 – 1998-12-31: -7342000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TREGA BIOSCIENCES INC · 1998-12-31 TREGA BIOSCIENCES INC (edgar:887920) Operating Cash Flow: -7342000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7342000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3785 The citation records this snapshot. The page link may show a newer release later.	USD 2.79 million Exact value Exact value: 2788000 USD 1998-01-01 – 1998-12-31: 2788000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TREGA BIOSCIENCES INC · 1998-12-31 TREGA BIOSCIENCES INC (edgar:887920) Capital Expenditure: 2788000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2788000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3790 The citation records this snapshot. The page link may show a newer release later.	−USD 10.13 million Calculation and evidence -7342000 − 2788000 USD Exact free cash flow: -10130000 USD 1998-01-01 – 1998-12-31: -7342000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 2788000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TREGA BIOSCIENCES INC · 1998-12-31 TREGA BIOSCIENCES INC (edgar:887920) Free cash flow: -10130000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7342000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3785 Input fundies:CapitalExpenditure: 2788000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3790 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 8.67 million Exact value Exact value: -8673000 USD 1999-01-01 – 1999-12-31: -8673000 USD Inspect Net Income Open source Share or cite Citation for Net Income · TREGA BIOSCIENCES INC · 1999-12-31 TREGA BIOSCIENCES INC (edgar:887920) Net Income: -8673000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8673000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3761 The citation records this snapshot. The page link may show a newer release later.	−USD 12.57 million Exact value Exact value: -12567000 USD 1999-01-01 – 1999-12-31: -12567000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TREGA BIOSCIENCES INC · 1999-12-31 TREGA BIOSCIENCES INC (edgar:887920) Operating Cash Flow: -12567000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12567000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3785 The citation records this snapshot. The page link may show a newer release later.	USD 1.66 million Exact value Exact value: 1656000 USD 1999-01-01 – 1999-12-31: 1656000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TREGA BIOSCIENCES INC · 1999-12-31 TREGA BIOSCIENCES INC (edgar:887920) Capital Expenditure: 1656000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1656000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3790 The citation records this snapshot. The page link may show a newer release later.	−USD 14.22 million Calculation and evidence -12567000 − 1656000 USD Exact free cash flow: -14223000 USD 1999-01-01 – 1999-12-31: -12567000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1656000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TREGA BIOSCIENCES INC · 1999-12-31 TREGA BIOSCIENCES INC (edgar:887920) Free cash flow: -14223000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887920?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12567000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3785 Input fundies:CapitalExpenditure: 1656000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887920/0000912057-00-011299.txt#3790 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

21 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000887920, 887920, edgar:887920

Also known as HOUGHTEN PHARMACEUTICALS INC

TREGA BIOSCIENCES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1999 1999-01-01 – 1999-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation